BDP1 and serous adenocarcinoma: Most patients with shortened disease‐free progression with BDP1 alterations had stage IIIC and stage IV serous ovarian cancer diagnosis in agreement with prior observations that most serous carcinomas are diagnosed at stage III (51%) or IV (29%).51